Clinical Outcomes With Recombinant Human C1 Inhibitor In The Repeat Treatment Of Acute Attacks Of Hereditary Angioedema In North-american Patients - 11/08/11
Doi : 10.1016/j.jaci.2010.12.406
B. Zuraw 1, T. Craig 2, R.F. Lockey 3, M. Park 4, J. Grant 5, D. Suez 6, L.B. Schwartz 7, M. Riedl 8, R.J. Levy 9, H.H. Li 10, L. Edara 11, J.A. Bernstein 12, J. Moy 13, J. Offenberger 14, A. Szema 15, A. Engler 16, S.M. Rehman 17, T.C. Marbury 18, O. Alpan 19, S.L. Bahna 20, A. Davis 21, G. Sussman 22, W.H. Yang 23, B. Ritchie 24, A. Relan 25
1 University of California San Diego, San Diego, CA
2 Penn State University, Hershey, PA
3 University of South Florida, Tampa, FL
4 Mayo Clinic, Rochester, MN
5 University of Texas Medical Branch, Galveston, TX
6 Allergy. Asthma and Immunology Clinic P.A., Irving, TX
7 Virginia Commenwealth University, Richmond, VA
8 UCLA, Los Angeles, CA
9 Family Allergy & Asthma Center, Atlanta, GA
10 Institute for Asthma and Allergy, Wheaton, MD
11 Asthma Allergy Centers of SW Michigan, Portage, MI
12 Bernstein Allergy group / Clinical Research Center, Cincinnati, OH
13 Rush University Medical Center, Chicago, IL
14 Allery & Asthma Institute of the Valley, Granada Hills, CA
15 SUNY Stony Brook School of Medicine, Stony Brook, NY
16 The Allergy and Asthma Clinic, San Mateo, CA
17 Asthma and Allergy Center, Toledo, OH
18 Orlando Clinical Research Center, Orlando, FL
19 Allergy-Immunology Clinical Trials Center, Springfield, VA
20 Louisiana State University Health Sciences Center, Shreveport, LA
21 Medical Research of Arizona, Scottsdale, AZ
22 Wellesley Central Health Corporation, West Toronto, ON, CANADA
23 Allergy and Asthma Research Center, Ottawa, ON, CANADA
24 University of Alberta, Edmonton, AB, CANADA
25 Pharming Technologies BV, Leiden, NETHERLANDS
379
Le texte complet de cet article est disponible en PDF.© 2011
Publié par Elsevier Masson SAS.
Vol 127 - N° 2S
P. AB101 - février 2011 Retour au numéro
Article précédent
- Xolair (omalizumab) in Treatment of Severe Refractory Chronic Idiopathic Urticaria
- G. Sussman, N. Leader, E. Merman, R. Melvin
- Effect of Anti-Ecallantide Antibodies on Tissue Factor Pathway Inhibitor Function
- D. Martik, G. Conley, J. Chen, S.R. Comeau, D.J. Sexton, C. Tenhoor
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?